Literature DB >> 27623143

Trends in the Distribution of Opioids in Puerto Rico, 1999-2013.

Sausan El Burai Félix1, Karin A Mack2, Christopher M Jones3.   

Abstract

OBJECTIVE: Limited information has been published about opioid prescribing practices in Puerto Rico. The objective of this study was to create baseline trends of opioids distributed over a period of fourteen years in Puerto Rico.
METHODS: We examined data from the U.S. Drug Enforcement Administration's Automation of Reports and Consolidated Orders System (ARCOS) for the period 1999-2013. ARCOS data reflects the amount of controlled substances legally dispensed. Analyses include the distribution of opioids (in morphine milligram equivalent kg per 10,000 persons) by year and entity (pharmacy, hospital, practitioner).
RESULTS: The distribution of four drugs (fentanyl, hydromorphone, methadone, oxycodone) increased over 100% between 1999 and 2013. The distribution of two drugs (hydrocodone and meperidine) declined between 1999 and 2013. Oxycodone distribution grew from 0.13 MME kg grams per 10,000 persons in 1999 to 0.29 MME kg in 2013.
CONCLUSION: ARCOS data showed that the overall amount of opioid pain relievers distributed in Puerto Rico increased by 68% between 1999 and 2013. Currently, prescription opioid pain reliever overdose deaths in Puerto Rico do not appear to be skyrocketing as they are in the mainland U.S. However, the ongoing problem with prescription opioid pain reliever overdoses in certain areas should serve as a warning to monitor consumption of opioid pain relievers, as well as changes in prescription drug abuse, overdoses, and deaths.

Entities:  

Keywords:  Overdose; Prescription drugs

Mesh:

Substances:

Year:  2016        PMID: 27623143      PMCID: PMC5683078     

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN: 0738-0658            Impact factor:   0.705


  6 in total

1.  Prevalence and correlates of substance use disorders among older adolescents in Puerto Rico and the United States: a cross-cultural comparison.

Authors:  L A Warner; G Canino; H M Colón
Journal:  Drug Alcohol Depend       Date:  2001-08-01       Impact factor: 4.492

2.  The economic burden of prescription drug use among elderly patients in Ponce, Puerto Rico.

Authors:  Laura López-Negrón; Homero A Monsanto-Planadeball
Journal:  P R Health Sci J       Date:  2006-06       Impact factor: 0.705

3.  Patterns of substance use onset among Hispanics in Puerto Rico and the United States.

Authors:  Mildred M Maldonado-Molina; Linda M Collins; Stephanie T Lanza; Guillermo Prado; Rafael Ramírez; Glorisa Canino
Journal:  Addict Behav       Date:  2007-04-14       Impact factor: 3.913

4.  Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: a report from the Global Opioid Policy Initiative (GOPI).

Authors:  J Cleary; L De Lima; J Eisenchlas; L Radbruch; J Torode; N I Cherny
Journal:  Ann Oncol       Date:  2013-12       Impact factor: 32.976

5.  [Prescription drug monitoring programs in the United States of America].

Authors:  Sausan El Burai Félix; Karin Mack
Journal:  Rev Panam Salud Publica       Date:  2014-10

6.  The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico.

Authors:  J C Reyes; J L Negrón; H M Colón; A M Padilla; M Y Millán; T D Matos; R R Robles
Journal:  J Urban Health       Date:  2012-06       Impact factor: 3.671

  6 in total
  2 in total

Review 1.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

2.  Opioid distribution trends (2006-2017) in the US Territories.

Authors:  Fedor F Cabrera; Erik R Gamarra; Tiffany E Garcia; Ashanti D Littlejohn; Poul A Chinga; Luis D Pinentel-Morillo; Jorge R Tirado; Daniel Y Chung; Leana J Pande; Kenneth L McCall; Stephanie D Nichols; Brian J Piper
Journal:  PeerJ       Date:  2019-01-15       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.